Javier Fuentes

2.2k total citations
24 papers, 733 citations indexed

About

Javier Fuentes is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Javier Fuentes has authored 24 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Epidemiology. Recurrent topics in Javier Fuentes's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Javier Fuentes is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). Javier Fuentes collaborates with scholars based in Spain, Mexico and United States. Javier Fuentes's co-authors include Ángel Lanas, Eduardo Bajador, Pedro Serrano, Ricardo Lemos Sainz, Miguel Montoro, Mercedes Sanz, Sofía Carreño, Raquel Sainz, Rafael Benito and P. Serrano and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Javier Fuentes

23 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier Fuentes Spain 11 370 319 270 189 106 24 733
Tushar Shukla Canada 7 205 0.6× 198 0.6× 72 0.3× 134 0.7× 45 0.4× 16 535
Fernando Borda Spain 14 413 1.1× 229 0.7× 155 0.6× 238 1.3× 201 1.9× 57 868
S.C. Sydney Chung Hong Kong 5 544 1.5× 512 1.6× 279 1.0× 317 1.7× 151 1.4× 8 892
María Angeles Pérez-Aisa Spain 5 574 1.6× 255 0.8× 158 0.6× 481 2.5× 133 1.3× 7 910
L Agostinis Italy 5 170 0.5× 190 0.6× 127 0.5× 113 0.6× 44 0.4× 7 550
M. Muñoz Spain 6 448 1.2× 143 0.4× 153 0.6× 405 2.1× 110 1.0× 14 759
Ming Hou Taiwan 11 167 0.5× 34 0.1× 80 0.3× 115 0.6× 87 0.8× 28 463
K.J. Ivey United States 10 222 0.6× 197 0.6× 74 0.3× 63 0.3× 52 0.5× 15 404
Jeffrey B. Raskin United States 14 1.1k 3.1× 165 0.5× 34 0.1× 158 0.8× 108 1.0× 30 1.4k
Nihal El Rouby United States 12 196 0.5× 48 0.2× 83 0.3× 154 0.8× 83 0.8× 24 617

Countries citing papers authored by Javier Fuentes

Since Specialization
Citations

This map shows the geographic impact of Javier Fuentes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Fuentes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Fuentes more than expected).

Fields of papers citing papers by Javier Fuentes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Fuentes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Fuentes. The network helps show where Javier Fuentes may publish in the future.

Co-authorship network of co-authors of Javier Fuentes

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Fuentes. A scholar is included among the top collaborators of Javier Fuentes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Fuentes. Javier Fuentes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sanz‐París, Alejandro, Yolanda González, Patricia Pérez‐Matute, et al.. (2022). Randomized Clinical Trial: Effects of β-Hydroxy-β-Methylbutyrate (HMB)-Enriched vs. HMB-Free Oral Nutritional Supplementation in Malnourished Cirrhotic Patients. Nutrients. 14(11). 2344–2344. 16 indexed citations
3.
Rodríguez, Manuel, J.M. Pascasio, Enrique Fraga, et al.. (2017). Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study. World Journal of Gastroenterology. 23(41). 7459–7469. 6 indexed citations
4.
Simón, Miguel Ángel, Marı́a Buti, M. Prieto, et al.. (2015). P0649 : Characterization of HBsAg loss in patients with chronic hepatitis B (CHB) treated with nucleos/tide analogs (NUCs): A retrospective multicenter study (HEBESAS). Journal of Hepatology. 62. S563–S564. 1 indexed citations
5.
Ortego, Javier, et al.. (2010). Prognostic value of lymph node micrometastases in patients with colorectal cancer in Dukes stages A and B (T1-T4, N0, M0). Revista Española de Enfermedades Digestivas. 102(3). 176–86. 13 indexed citations
6.
Ortego, Javier, et al.. (2009). Prognostic Value of Microvascular Density in Dukes A and B (T1–T4, N0, M0) Colorectal Carcinomas. Gastroenterology Research and Practice. 2009. 1–7. 7 indexed citations
7.
Zenteno‐Cuevas, Roberto, et al.. (2008). Detección de Mycobacteria en muestras de expectoración, mediante amplificación del marcador rADN16S por la reacción en cadena de la polimerasa. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 33(1). 4–9. 2 indexed citations
8.
Fuentes, Javier, et al.. (2008). Diagnóstico y tratamiento de los quistes de colédoco: Presentación de 10 nuevos casos. Revista Española de Enfermedades Digestivas. 100(2). 71–5. 8 indexed citations
9.
Piazuelo, Elena, Javier Fuentes, María Asunción García-González, Pilar Jiménez, & Ángel Lanas. (2008). A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin. Clinical Therapeutics. 30(1). 121–130. 18 indexed citations
10.
Gisbert, Javier P., Javier Fuentes, Daniel Carpio, et al.. (2005). 7‐day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure. Alimentary Pharmacology & Therapeutics. 21(10). 1249–1253. 10 indexed citations
11.
Lanas, Ángel, Pedro Serrano, Eduardo Bajador, Javier Fuentes, & Ricardo Lemos Sainz. (2003). Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. European Journal of Gastroenterology & Hepatology. 15(2). 173–178. 50 indexed citations
12.
Lanas, Ángel, Javier Fuentes, Rafael Benito, et al.. (2002). Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low‐dose aspirin. Alimentary Pharmacology & Therapeutics. 16(4). 779–786. 157 indexed citations
13.
García‐García, Lourdes, Alfredo Ponce‐de‐León, Leticia Ferreyra-Reyes, et al.. (2002). Tuberculosis-Related Deaths within a Well-Functioning DOTS Control Program. Emerging infectious diseases. 8(11). 1327–1333. 44 indexed citations
14.
Lanas, Ángel, Eduardo Bajador, Pedro Serrano, et al.. (2000). Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal Bleeding. New England Journal of Medicine. 343(12). 834–839. 324 indexed citations
15.
Fuentes, Javier, et al.. (2000). Caso clínico varón con dolor abdominal agudo, vómitos y dilatación secundaria de vía biliar. Medicine - Programa de Formación Médica Continuada Acreditado. 8(12). 661–664. 1 indexed citations
16.
Lanas, Ángel, et al.. (2000). Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Gastroenterology. 118(4). A252–A252. 30 indexed citations
17.
Gomollón, Fernando, et al.. (1998). The Ideal Therapy Must Be Def ined in Each Geographical Area: Experience with a Quadruple Therapy in Spain. Helicobacter. 3(2). 110–114. 11 indexed citations
18.
Lanas, Ángel, Eduardo Bajador, Pedro Serrano, et al.. (1998). Effects of Nitrate and Prophylactic Aspirin on Upper Gastrointestinal Bleeding: A Retrospective Case–Control Study. Journal of International Medical Research. 26(3). 120–128. 9 indexed citations
19.
Val, J López del, et al.. (1998). [Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].. PubMed. 21(9). 432–6. 6 indexed citations
20.
Pallarés, Román, et al.. (1984). [Etiopathogenic factors possibly implicated in hepatic dysfunction associated with parenteral nutrition: prospective study of 104 adult patients].. PubMed. 83(20). 832–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tushar Shukla Breakdown of academic impact, for papers by Fernando Borda Breakdown of academic impact, for papers by S.C. Sydney Chung Breakdown of academic impact, for papers by María Angeles Pérez-Aisa Breakdown of academic impact, for papers by L Agostinis Breakdown of academic impact, for papers by M. Muñoz Breakdown of academic impact, for papers by Ming Hou Breakdown of academic impact, for papers by K.J. Ivey Breakdown of academic impact, for papers by Jeffrey B. Raskin Breakdown of academic impact, for papers by Nihal El Rouby
Rankless by CCL
2026